Cargando…
OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
Autores principales: | Kannanganat, S, Nigam, P, Velu, V, Earl, P, Lai, L, Lawson, B, Chennareddi, L, Wilson, R, Kozlowski, P, Moss, B, Robinson, H, Amara, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767575/ http://dx.doi.org/10.1186/1742-4690-6-S3-O51 |
Ejemplares similares
-
GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
por: Robinson, H, et al.
Publicado: (2012) -
Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade
por: Velu, Vijayakumar, et al.
Publicado: (2008) -
PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
por: Velu, Vijayakumar, et al.
Publicado: (2022) -
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012) -
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
por: Nigam, Pragati, et al.
Publicado: (2007)